Sep 13, 2021 / 01:30PM GMT
Michael Klaus Jungling - Morgan Stanley, Research Division - MD, Head of MedTech & Services and Analyst
So a warm welcome to another virtual fireside chat at the Morgan Stanley Global Healthcare Conference. I'm delighted to have QIAGEN with us today, a leader in molecular diagnostics. My name is Mike Jungling, and I'll be a moderator for this session. We have 30 minutes for this call. (Operator Instructions) I've been asked by our compliance department to quickly mention a couple of disclaimers.
And here I go. This webcast is not for members of the press. If you are members of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley website, which is www.morganstanley.com/researchdisclosures. And if you have any questions, please contact your sales representative.
It's now with good pleasure to introduce Roland Sackers, CFO of QIAGEN, but we also have with us today John Gilardi, VP of Investor Relations. And with this, I would like to hand
Qiagen NV at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers